SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (1149)12/10/2001 8:33:36 PM
From: jayhawk969  Respond to of 1475
 
"Could you help me on the pro's and con's of a shelf
registration as opposed to a straight out underwriter
deal for the shares being issued all at once. "

No I really can't. I would be guessing. Your statement
sounds good to me.
NBIX announced their shelf on 11.13, their preliminary prospectus on 11.27,
and priced it on 12.3. Sepracor did theirs in a one night deal, and although unusual it
dropped and took a couple of
weeks to recover.

NBIX historical price as follows:

12/10/2001 47.550
12/07/2001 49.360
12/06/2001 50.400
12/05/2001 49.690
12/04/2001 49.700
12/03/2001 47.340
11/30/2001 47.590
11/29/2001 48.000
11/28/2001 45.850
11/27/2001 44.970
11/26/2001 48.030
11/23/2001 47.900
11/21/2001 47.940
11/20/2001 45.480
11/19/2001 43.610
11/16/2001 41.600
11/15/2001 41.550
11/14/2001 42.410
11/13/2001 42.800



To: Arthur Radley who wrote (1149)12/10/2001 8:40:27 PM
From: ewolf  Read Replies (1) | Respond to of 1475
 
Why does this make you nervous? Isn't this part of the bargain for a developing biotech? Is it that you wanted them to wait until the stock price is higher?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News